The presence of oscillations in peripheral insulin concentrations has sparked a number of studies evaluating the impact of
the insulin release pattern on the action of insulin on target organs. These have convincingly shown that equal amounts of
insulin presented to target organs have improved action when delivered in a pulsatile manner. In addition, impaired (not absent)
pulsatility of insulin secretion has been demonstrated in Type II (non-insulin-dependent) diabetes mellitus, suggesting a
possible mechanism to explain impaired insulin action in Type II diabetes. Whereas the regulation of overall insulin secretion
has been described in detail, the mechanisms by which this regulation affects the pulsatile insulin secretory pattern, and
the relative and absolute contribution of changes in the characteristics of pulsatile insulin release have not been reviewed
previously. This review will focus on the importance of the secretory bursts to overall insulin release, and on how insulin
secretion is adjusted by changes in these secretory bursts. Detection and quantification of secretory bursts depend on methods,
and the methodology involved in studies dealing with pulsatile insulin secretion is described. Finally, data suggest that
impaired pulsatile insulin secretion is an early marker for beta-cell dysfunction in Type II diabetes, and the role of early
detection of impaired pulsatility to predict diabetes or to examine mechanisms to cause beta-cell dysfunction is mentioned.
[Diabetologia (2002) 45: 3–20]
Keywords Insulin - pulsatility oscillation - diabetes - physiology - secretion - regulation - C peptide.
Received: 9 November 2000 and in revised form: 26 July 2001